Catheter Precision (VTAK) Cash from Operations Growth (1y) (2018 - 2026)
Catheter Precision (VTAK) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 122.43% |
| 10 | Catheter Precision | 608,671.48 | 208,671.48 | 390,000.00 | -19.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.59% |
| Dec 31, 2025 | 47.07% |
| Sep 30, 2025 | 21.10% |
| Jun 30, 2025 | -33.29% |
| Mar 31, 2025 | -20.39% |
| Dec 31, 2024 | -51.61% |
| Sep 30, 2024 | -51.26% |
| Jun 30, 2024 | 64.99% |
| Mar 31, 2024 | 83.89% |
| Dec 31, 2023 | 37.55% |
| Sep 30, 2023 | 63.15% |
| Jun 30, 2023 | 19.32% |
| Mar 31, 2023 | -40.66% |
| Dec 31, 2022 | 47.03% |
| Sep 30, 2022 | 31.17% |
| Jun 30, 2022 | 9.26% |
| Mar 31, 2022 | -6.08% |
| Dec 31, 2021 | 39.34% |
| Sep 30, 2021 | -19.32% |
| Jun 30, 2021 | -14.16% |